Zachery Carter
HomeProductsFAQSign In
© 2026 Zachery Carter. All rights reserved.
ProductsFAQadmin@mypeptide.net(850) 384-0430Sign In
Legal
MyPeptide Privacy PolicyShipping and Returns PolicyMyPeptide Terms and Conditions
FDA DISCLAIMER

Statements made regarding our products have not been evaluated by the U.S. Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. Products are not intended to diagnose, treat, cure, or prevent any disease. Information presented on this website is not a substitute for, or alternative to, information from a qualified health care practitioner. Please consult a licensed health care professional regarding any potential interactions or complications before using any product. This notice is required under the Federal Food, Drug, and Cosmetic Act.

HomeShopSign In

Researcher verification

MyPeptide sells research peptides exclusively to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

By proceeding you affirm the statements above are true. Products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration.

© 2026 MyPeptide.net all rights reserved
Back to catalog
AOD 9604 (5mg)
Metabolic Research
Research Use Only — Not for Human or Veterinarian Administration

AOD 9604 (5mg)

AOD-9604 is a modified fragment of human growth hormone (amino acids 176–191) studied in research models for lipolytic activity without the somatogenic effects of full-length GH.

Select size

lyophilized
$40.00/ AOD 9604 (5mg)
Certificate of Analysis — AOD 9604 (5mg)Certificate of AnalysisThird-party HPLC lab report · opens PDF

For laboratory and research use only. Not for human or veterinary use.

Mechanism of Action

AOD-9604 mimics the lipolytic domain of GH, activating beta-3 adrenergic receptors and downstream fat metabolism pathways in adipocyte research models without significant IGF-1 elevation.

Research Applications

  • Adipocyte lipolysis assays
  • Beta-3 adrenergic receptor studies
  • Comparative GH fragment research

Specifications

sequenceH-Tyr-Leu-Arg-Ile-Val-Gln-Cys-Arg-Ser-Val-Glu-Gly-Ser-Cys-Gly-Phe-OH (modified fragment)
molecular Weight1815.1 Da
cas221231-10-3
appearanceWhite lyophilized powder

Reconstitution (Laboratory)

Reconstitute with bacteriostatic water. Standard sterile technique.

Storage & Handling

Lyophilized: 2–8 °C. Reconstituted: refrigerate.

Quality Assurance

Every lot undergoes independent third-party HPLC purity analysis, mass spectrometry identity confirmation, and endotoxin testing (<0.5 EU/mg). Certificate of Analysis (COA) is stored against the SKU lot number and available through your research account portal.

Sources & References

  1. 1.Heffernan MA, et al. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism. J Endocrinol. 2001. · PubMed →
  2. 2.Ng FM, et al. Metabolic studies of a synthetic lipolytic domain of human growth hormone. Horm Res. 2000. · PubMed →